; and (2) to report accidents, near-accidents, or other safety incidents involving biological agents and toxins to the Secretary. (c) Board The Secretary shall establish a Board consisting of a representative from each entity in receipt of an award under subsection (a), which shall be headed by an executive committee of 3 members elected upon an affirmative vote from a majority of such representatives. The Board shall make recommendations to the Secretary in administering awards under this section, for purposes of— (1) improving the quality and consistency of applicable procedures and practices within laboratories funded pursuant to subsection (a); and (2) ensuring coordination, as appropriate, of federally funded activities carried out at such laboratories. (d) Definition In this section, the term regional biocontainment laboratory means a Biosafety or Animal Biosafety Level-3 and Level-2 facility located at an institution in the United States that is designated by the Secretary to carry out the activities described in subsection (a). (e) Authorization of appropriations To carry out this section, there are authorized to be appropriated $52,000,000 for each of fiscal years 2024 through 2028. (f) Administrative expenses Of the amount available to carry out this section for a fiscal year, the Secretary may use not more than 5 percent for the administrative expenses of carrying out this section, including expenses related to carrying out subsection (c). (g) Report to Congress Not later than 1 year after the date of the enactment of this Act, and biannually thereafter, the Secretary, in consultation with the heads of applicable Federal departments and agencies shall report to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives on— (1) the activities and accomplishments of the regional biocontainment laboratories